AN2 Therapeutics (ANTX) P/E (2022 - 2026)
AN2 Therapeutics (ANTX) P/E from Mar 25, 2022 to Jul 20, 2026. The TTM AN2 Therapeutics (ANTX) P/E is -4.09. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of AN2 Therapeutics (ANTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -4.09 | +347.81% |
| 2025 | -0.91 | +13.75% |
| 2024 | -0.80 | -89.50% |
| 2023 | -7.64 | +61.48% |
| 2022 | -4.73 | N/A |
Comparison AN2 Therapeutics (ANTX) P/E with competitors
AN2 Therapeutics (ANTX) P/E is -4.09.